SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950137-06-003293
Filing Date
2006-03-20
Accepted
2006-03-20 16:41:04
Documents
4
Period of Report
2006-03-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K a18710e8vk.htm 8-K 24947
2 EXHIBIT 10.1 a18710exv10w1.htm EX-10.1 63374
3 EXHIBIT 10.2 a18710exv10w2.htm EX-10.2 41259
4 EXHIBIT 99.1 a18710exv99w1.htm EX-99.1 12714
  Complete submission text file 0000950137-06-003293.txt   143967
Mailing Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121
Business Address 6455 NANCY RIDGE DR SAN DIEGO CA 92121 8584526600
LA JOLLA PHARMACEUTICAL CO (Filer) CIK: 0000920465 (see all company filings)

IRS No.: 330361285 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-24274 | Film No.: 06699028
SIC: 2836 Biological Products, (No Diagnostic Substances)